Cytek Biosciences, Inc.
CTKB
$4.20
-$0.16-3.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -0.08% | -0.11% | -1.35% | -4.41% | 0.03% |
| Total Receivables | 16.95% | 8.83% | 2.65% | -8.88% | 15.06% |
| Inventory | -6.27% | 3.94% | 9.40% | 3.72% | -6.08% |
| Prepaid Expenses | 141.84% | -29.24% | -7.78% | -33.60% | 109.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -72.98% | 1.52% | 5.19% | 30.45% | -24.06% |
| Total Current Assets | 0.90% | 1.48% | 0.61% | -4.02% | 1.60% |
|
|
|||||
| Total Current Assets | 0.90% | 1.48% | 0.61% | -4.02% | 1.60% |
| Net Property, Plant & Equipment | 0.41% | -15.93% | 25.40% | -1.52% | -1.75% |
| Long-term Investments | -0.01% | -0.05% | 0.17% | 0.09% | 2.97% |
| Goodwill | -0.01% | -0.05% | 0.17% | 0.09% | 2.97% |
| Total Other Intangibles | -4.84% | -4.97% | -4.27% | -3.46% | -1.78% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -87.63% | 6.19% | 5.90% | -3.80% | 11.74% |
| Total Assets | -6.74% | 0.32% | 2.22% | -3.38% | 1.68% |
|
|
|||||
| Total Accounts Payable | -16.01% | 11.37% | 9.70% | 12.99% | 2.60% |
| Total Accrued Expenses | 16.12% | -1.99% | 12.00% | -8.93% | 7.80% |
| Short-term Debt | 0.00% | -57.14% | -41.67% | -42.28% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.90% | 36.73% | 43.64% | -39.02% | 52.26% |
| Total Finance Division Other Current Liabilities | 5.18% | -0.87% | 3.99% | 6.65% | 0.84% |
| Total Other Current Liabilities | 5.18% | -0.87% | 3.99% | 6.65% | 0.84% |
| Total Current Liabilities | 3.45% | 2.64% | 8.24% | 0.04% | 7.75% |
|
|
|||||
| Total Current Liabilities | 3.45% | 2.64% | 8.24% | 0.04% | 7.75% |
| Long-Term Debt | -19.85% | -17.19% | -13.83% | -12.57% | -15.05% |
| Short-term Debt | 0.00% | -57.14% | -41.67% | -42.28% | -- |
| Capital Leases | 4.06% | -4.43% | 89.57% | -1.38% | -2.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.63% | -2.14% | 2.48% | -2.12% | -19.06% |
| Total Liabilities | 2.97% | 0.51% | 12.42% | -0.76% | -1.89% |
|
|
|||||
| Common Stock & APIC | 1.34% | 1.31% | 0.69% | -0.95% | 0.17% |
| Retained Earnings | -76.44% | -10.50% | -11.98% | -32.39% | 21.50% |
| Treasury Stock & Other | 172.96% | 2,260.53% | 93.76% | -3,906.25% | -84.16% |
| Total Common Equity | -9.73% | 0.27% | -0.54% | -4.07% | 2.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.73% | 0.27% | -0.54% | -4.07% | 2.67% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.73% | 0.27% | -0.54% | -4.07% | 2.67% |
|
|
|||||